vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and SCOTTS MIRACLE-GRO CO (SMG). Click either name above to swap in a different company.

SCOTTS MIRACLE-GRO CO is the larger business by last-quarter revenue ($354.4M vs $77.6M, roughly 4.6× Bioceres Crop Solutions Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -35.3%, a 25.7% gap on every dollar of revenue. On growth, SCOTTS MIRACLE-GRO CO posted the faster year-over-year revenue change (-15.0% vs -16.8%). Over the past eight quarters, Bioceres Crop Solutions Corp.'s revenue compounded faster (-8.4% CAGR vs -51.8%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

The Scotts Miracle-Gro Company is an American multinational corporation headquartered in Marysville, Ohio, where O.M. Scott began selling lawn seed in 1868. The company manufactures and sells consumer lawn, garden and pest control products, as well as soilless indoor gardening equipment. In the U.S., the company manufactures Scotts, Miracle-Gro and Ortho brands. It also markets and distributes the herbicide Roundup in the U.S. and several international markets including China.

BIOX vs SMG — Head-to-Head

Bigger by revenue
SMG
SMG
4.6× larger
SMG
$354.4M
$77.6M
BIOX
Growing faster (revenue YoY)
SMG
SMG
+1.8% gap
SMG
-15.0%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
25.7% more per $
BIOX
-9.6%
-35.3%
SMG
Faster 2-yr revenue CAGR
BIOX
BIOX
Annualised
BIOX
-8.4%
-51.8%
SMG

Income Statement — Q1 2026 vs Q1 2026

Metric
BIOX
BIOX
SMG
SMG
Revenue
$77.6M
$354.4M
Net Profit
$-7.4M
$-125.0M
Gross Margin
46.8%
25.0%
Operating Margin
9.3%
-6.2%
Net Margin
-9.6%
-35.3%
Revenue YoY
-16.8%
-15.0%
Net Profit YoY
-20.2%
-79.9%
EPS (diluted)
$-0.12
$-2.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
SMG
SMG
Q4 25
$354.4M
Q3 25
$77.6M
$387.3M
Q2 25
$1.2B
Q1 25
$60.6M
$1.4B
Q4 24
$98.8M
$416.8M
Q3 24
$93.3M
$414.7M
Q2 24
$1.2B
Q1 24
$84.0M
$1.5B
Net Profit
BIOX
BIOX
SMG
SMG
Q4 25
$-125.0M
Q3 25
$-7.4M
Q2 25
$149.1M
Q1 25
$-1.6M
$217.5M
Q4 24
$605.2K
$-69.5M
Q3 24
$-6.2M
Q2 24
$132.1M
Q1 24
$9.8M
$157.5M
Gross Margin
BIOX
BIOX
SMG
SMG
Q4 25
25.0%
Q3 25
46.8%
6.1%
Q2 25
31.8%
Q1 25
39.4%
38.6%
Q4 24
42.0%
22.7%
Q3 24
40.2%
-7.1%
Q2 24
29.5%
Q1 24
50.8%
30.4%
Operating Margin
BIOX
BIOX
SMG
SMG
Q4 25
-6.2%
Q3 25
9.3%
-38.8%
Q2 25
18.1%
Q1 25
1.5%
24.3%
Q4 24
14.5%
-12.2%
Q3 24
2.5%
-52.1%
Q2 24
16.6%
Q1 24
15.7%
17.8%
Net Margin
BIOX
BIOX
SMG
SMG
Q4 25
-35.3%
Q3 25
-9.6%
Q2 25
12.6%
Q1 25
-2.6%
15.3%
Q4 24
0.6%
-16.7%
Q3 24
-6.6%
Q2 24
11.0%
Q1 24
11.6%
10.3%
EPS (diluted)
BIOX
BIOX
SMG
SMG
Q4 25
$-2.16
Q3 25
$-0.12
$-2.58
Q2 25
$2.54
Q1 25
$-0.02
$3.72
Q4 24
$0.00
$-1.21
Q3 24
$-0.10
$-4.21
Q2 24
$2.28
Q1 24
$0.14
$2.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
SMG
SMG
Cash + ST InvestmentsLiquidity on hand
$15.5M
$8.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$-500.6M
Total Assets
$734.9M
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
SMG
SMG
Q4 25
$8.3M
Q3 25
$15.5M
$36.6M
Q2 25
$51.1M
Q1 25
$38.5M
$16.9M
Q4 24
$29.2M
$9.8M
Q3 24
$32.3M
$71.6M
Q2 24
$279.9M
Q1 24
$16.4M
$65.1M
Total Debt
BIOX
BIOX
SMG
SMG
Q4 25
Q3 25
$2.1B
Q2 25
Q1 25
Q4 24
Q3 24
$2.2B
Q2 24
Q1 24
Stockholders' Equity
BIOX
BIOX
SMG
SMG
Q4 25
$-500.6M
Q3 25
$288.3M
$-357.5M
Q2 25
$-170.9M
Q1 25
$345.0M
$-290.1M
Q4 24
$346.3M
$-479.5M
Q3 24
$346.0M
$-390.6M
Q2 24
$-146.2M
Q1 24
$348.5M
$-250.9M
Total Assets
BIOX
BIOX
SMG
SMG
Q4 25
$3.0B
Q3 25
$734.9M
$2.7B
Q2 25
$3.1B
Q1 25
$798.2M
$3.5B
Q4 24
$835.2M
$3.2B
Q3 24
$827.3M
$2.9B
Q2 24
$3.5B
Q1 24
$836.1M
$3.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
SMG
SMG
Operating Cash FlowLast quarter
$14.4M
$-370.4M
Free Cash FlowOCF − Capex
$-390.4M
FCF MarginFCF / Revenue
-110.2%
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$358.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
SMG
SMG
Q4 25
$-370.4M
Q3 25
$14.4M
$174.1M
Q2 25
$454.4M
Q1 25
$23.3M
$188.1M
Q4 24
$-5.4M
$-445.3M
Q3 24
$5.2M
$118.5M
Q2 24
$588.0M
Q1 24
$-17.4M
$304.2M
Free Cash Flow
BIOX
BIOX
SMG
SMG
Q4 25
$-390.4M
Q3 25
$131.2M
Q2 25
$437.5M
Q1 25
$179.8M
Q4 24
$-474.6M
Q3 24
$101.9M
Q2 24
$574.8M
Q1 24
$287.9M
FCF Margin
BIOX
BIOX
SMG
SMG
Q4 25
-110.2%
Q3 25
33.9%
Q2 25
36.8%
Q1 25
12.7%
Q4 24
-113.9%
Q3 24
24.6%
Q2 24
47.8%
Q1 24
18.9%
Capex Intensity
BIOX
BIOX
SMG
SMG
Q4 25
5.6%
Q3 25
11.1%
Q2 25
1.4%
Q1 25
0.6%
Q4 24
7.0%
Q3 24
4.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
BIOX
BIOX
SMG
SMG
Q4 25
Q3 25
Q2 25
3.05×
Q1 25
0.86×
Q4 24
-8.85×
Q3 24
Q2 24
4.45×
Q1 24
-1.78×
1.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

SMG
SMG

Growing Media And Mulch$111.5M31%
Lawn Care$109.5M31%
Controls$59.8M17%
Other Products Primarily Gardening$23.9M7%
Restated Marketing Agreement$19.4M5%
Growingmedia$12.6M4%
Otherprimarilygardeningandcontrols$10.2M3%
Other$7.5M2%

Related Comparisons